×
Tuesday, May 21, 2024

INVESTOR ALERT: Berger Montague Advises Charles River Laboratories International, Inc. (CRL) Investors to Inquire About a Securities Fraud Action by July 18, 2023

Last updated Tuesday, May 23, 2023 15:05 ET

Vancouver Canada · V6E 4A6, Canada, 05/23/2023 / SubmitMyPR /

Philadelphia, Pennsylvania--(Newsfile Corp. - May 23, 2023) - Berger Montague advises investors that a securities fraud class action lawsuit has been filed against Charles River Laboratories International, Inc. ("Charles River") (NYSE: CRL) on behalf of those who purchased Charles River securities between May 7, 2020 and February 21, 2023, inclusive (the "Class Period").

Deadline To Request Appointment As Lead Plaintiff: July 18, 2023

To learn more about this litigation, visit:
https://investigations.bergermontague.com/charles-river-laboratories-securities-investigation/

For additional information about this litigation, contact: 

James Maro
[email protected]
(267) 637-3176

Andrew Abramowitz
[email protected]
(215) 875-3015 or visit: https://investigations.bergermontague.com/charles-river-laboratories-securities-investigation/

The complaint alleges that throughout the Class Period, the defendants failed to disclose to investors that: (1) Charles River had engaged in illegal activity with respect to its importation of non-human primates for research; (2) as a result, Charles River was at a heightened risk of criminal and regulatory investigation by, inter alia, the DOJ; (3) as a result, Charles River would be forced to suspend shipments of primates from Cambodia; and (4) as a result of the foregoing, Defendants' positive statements about Charles River's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Communicating with any counsel is not necessary to participate or share in any recovery achieved in this case. Any member of the purported class may move the Court to serve as a lead plaintiff through counsel of his/her choice, or may choose to do nothing and remain an inactive class member.

Berger Montague, with offices in Philadelphia, Minneapolis, Washington, D.C., San Diego, San Francisco, Chicago, and Toronto has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.

Contacts:
James Maro, Senior Counsel
Berger Montague
(267) 637-3176
[email protected]

Andrew Abramowitz, Senior Counsel
Berger Montague
(215) 875-3015
[email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/167133

Original Source of the original story >> INVESTOR ALERT: Berger Montague Advises Charles River Laboratories International, Inc. (CRL) Investors to Inquire About a Securities Fraud Action by July 18, 2023